A detailed history of Liberty Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Liberty Capital Management, Inc. holds 7,729 shares of PFE stock, worth $205,282. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,729
Previous 7,729 -0.0%
Holding current value
$205,282
Previous $216,000 3.24%
% of portfolio
0.05%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$25.26 - $29.6 $13,160 - $15,421
521 Added 7.23%
7,729 $216,000
Q1 2024

Apr 11, 2024

SELL
$25.89 - $29.73 $3,391 - $3,894
-131 Reduced 1.78%
7,208 $200,000
Q4 2022

Jan 23, 2023

SELL
$41.75 - $54.5 $6,262 - $8,175
-150 Reduced 2.0%
7,339 $0
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $327,718 - $400,062
7,489 New
7,489 $328,000
Q1 2021

Apr 19, 2021

SELL
$33.49 - $37.77 $13,563 - $15,296
-405 Reduced 5.0%
7,690 $279,000
Q4 2020

Jan 20, 2021

BUY
$33.47 - $42.56 $133 - $170
4 Added 0.05%
8,095 $298,000
Q1 2020

Apr 13, 2020

SELL
$27.03 - $38.62 $34,463 - $49,240
-1,275 Reduced 13.61%
8,091 $264,000
Q4 2019

Jan 21, 2020

SELL
$32.92 - $37.36 $3,292 - $3,736
-100 Reduced 1.06%
9,366 $367,000
Q3 2019

Oct 15, 2019

SELL
$32.49 - $42.13 $4,256 - $5,519
-131 Reduced 1.37%
9,466 $340,000
Q1 2019

Apr 22, 2019

SELL
$37.5 - $41.2 $13,125 - $14,420
-350 Reduced 3.52%
9,597 $408,000
Q4 2018

Jan 24, 2019

SELL
$38.47 - $43.86 $8,540 - $9,736
-222 Reduced 2.18%
9,947 $434,000
Q3 2018

Oct 26, 2018

SELL
$34.47 - $41.81 $44,811 - $54,353
-1,300 Reduced 11.33%
10,169 $448,000
Q1 2018

Apr 25, 2018

SELL
$31.91 - $37.02 $3,510 - $4,072
-110 Reduced 0.95%
11,469 $407,000
Q3 2017

Oct 25, 2017

BUY
$31.0 - $34.15 $358,949 - $395,422
11,579
11,579 $422,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Liberty Capital Management, Inc. Portfolio

Follow Liberty Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Capital Management, Inc. with notifications on news.